Biocon Limited has informed the Exchange regarding a press release dated September 17, 2025, titled "Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya and Aukelso , Denosumab Biosimilars".
Biocon Limited has informed the Exchange regarding a press release dated September 17, 2025, titled "Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya and Aukelso , Denosumab Biosimilars".